View drug registration information details.
Items | Registration information |
ID | 287 |
No | 287 |
Brand Name | AZIMAX-250 |
Ingredients | AZITHROMYCIN DIHYDRATE 262.05 MG EQ.TO AZITHROMYCIN 250 MG |
Dosage Form | FILM COATED TABLET |
Primary Packaging | BLISTERPACK |
Storage | |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 1 X 6'S, 5 X 6'S |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | BRONCHITIS, COMUNITY-ACQUIRED PNEUMONIA, SINUSITIS, PHARYNGITIS/TONSILITIS, OTITIS MEDIA, SKIN AND SOFT TISSUE INFECTION, UNCOMPLICATED GENITAL INFECTION DUE TO CHLAMYDIA TRACHOMATIS |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | OBLONG, WHITE FILM-COATED TABLET, BEVEL-EDGED, SHALLOW CONVEX WITH BREAK-BAR ON ONE SIDE AND HOVID EMBOSSED ON THE OTHER SIDE |
Note | |
License Owner | BMS PHARMA SOLE CO.,LTD |
Manufacturer | HOVID BHD |
Country | MALAYSIA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 04 I 4686/19 |
FDD Registration Date | 07-JUL-2025 |
Expiry Date | 06-JUL-2030 |
Back to drug list
|